(2021). Combined GIP/GLP-1 Agonist: Safe for Type 2 Diabetes Patients? Internal Medicine Alert, 43(18), 1.
Chicago Style (17th ed.) Citation"Combined GIP/GLP-1 Agonist: Safe for Type 2 Diabetes Patients?" Internal Medicine Alert 43, no. 18 (2021): 1.
MLA (9th ed.) Citation"Combined GIP/GLP-1 Agonist: Safe for Type 2 Diabetes Patients?" Internal Medicine Alert, vol. 43, no. 18, 2021, p. 1.
Warning: These citations may not always be 100% accurate.
